Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PureTech Health PLC (GB:PRTC)
LSE:PRTC
Holding GB:PRTC?
Track your performance easily
PRTC Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range139.00p - 238.50p
Previous Close142.6p
Volume47.75K
Average Volume (3M)498.95K
Market Cap
£341.39M
Enterprise Value107.28M
Total Cash (Recent Filing)$327.14M
Total Debt (Recent Filing)$25.34M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
Apr 24, 2025EPS Estimate
-£0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding239,421,312
10 Day Avg. Volume743,095
30 Day Avg. Volume498,953
Standard Deviation0.11
R-Squared0.15
Alpha-0.00656
Financial Highlights & Ratios
Price to Book (P/B)108.03
Price to Sales (P/S)611.59
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit32.21
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
455.00pPrice Target Upside216.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
PureTech Health News
PremiumCompany Announcements
Citigroup Adjusts Stake in PureTech Health
PremiumCompany Announcements
Vor Bio’s Positive Clinical Data Offers AML Treatment Hope
PremiumCompany Announcements
PureTech Health’s Strong H1 2024 Performance
PremiumCompany Announcements
PureTech Health Addresses AGM Concerns, Advances Pipeline
PremiumCompany Announcements
PureTech Health Welcomes New Board MemberPremiumCompany Announcements
PureTech Health Set to Unveil Mid-Year Financials
PremiumCompany Announcements
Seaport Therapeutics Bolsters Board with Pharma ExpertOptions Prices
Currently, No data available
---
Ownership Overview
10.15% Insiders
12.77% Mutual Funds
4.35% Other Institutional Investors
72.73% Public Companies and
Individual Investors
PRTC FAQ
What was PureTech Health PLC’s price range in the past 12 months?
PureTech Health PLC lowest share price was 139.00p and its highest was 238.50p in the past 12 months.
What is PureTech Health PLC’s market cap?
Currently, no data Available
When is PureTech Health PLC’s upcoming earnings report date?
PureTech Health PLC’s upcoming earnings report date is Apr 24, 2025 which is in 216 days.
How were PureTech Health PLC’s earnings last quarter?
PureTech Health PLC released its earnings results on Aug 28, 2024. The company reported -0.114p earnings per share for the quarter, beating the consensus estimate of -0.231p by 0.116p.
Is PureTech Health PLC overvalued?
According to Wall Street analysts PureTech Health PLC’s price is currently Undervalued.
Does PureTech Health PLC pay dividends?
PureTech Health PLC does not currently pay dividends.
What is PureTech Health PLC’s EPS estimate?
PureTech Health PLC’s EPS estimate is -£0.21.
How many shares outstanding does PureTech Health PLC have?
PureTech Health PLC has 239,404,190 shares outstanding.
What happened to PureTech Health PLC’s price movement after its last earnings report?
PureTech Health PLC reported an EPS of -0.114p in its last earnings report, beating expectations of -0.231p. Following the earnings report the stock price went up 2.788%.
Which hedge fund is a major shareholder of PureTech Health PLC?
Currently, no hedge funds are holding shares in GB:PRTC
---
PureTech Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
455.00p (216.85% Upside)
455.00p (216.85% Upside)
Insider Transactions
Sold Shares
Worth £1.9M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.53%
12-Months-Change
Fundamentals
Return on Equity
-20.03%
Trailing 12-Months
Asset Growth
-15.90%
Trailing 12-Months
Company Description
PureTech Health PLC
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on areas of growing scientific and technical insights that it believes are at an important inflection point, including the central nervous, gastrointestinal and immune systems, and the interactions and signaling between them. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of the society's healthcare needs.
---
PRTC Stock 12 Month Forecast
Average Price Target
455.00p
▲(216.85% Upside)
Technical Analysis
Best Analysts Covering PRTC
1 Year
1 Year Success Rate
2/10 ratings generated profit
1 Year Average Return
-7.93%
reiterated a buy rating 3 months ago
Copying Peter Welford's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -7.93% per trade.
---